Silver Sulfadiazine Market - Global Industry
Analysis, Size, Share, Growth, Trends and
Forecast 2014 - 2020
Silver sulfadiazine is an antibacterial drug used for making personal care products
such as anti-burn creams. Silver sulfadiazine is listed in the World Health
Organization’s List of Essential Medicines and is widely used as an antibiotic for
treating second and third degree burns on the skin. Silver sulfadiazine prevents the
growth of bacteria and yeast on the skin. This drug is also commonly used to treat
urinary tract infections (UTIs). Sulfadiazine, when combined with pyrimethamine, is
used for curing the disease Toxoplasmosis. The typical Silver sulfadiazine anti-burn
lotion/creams contain 1 percent silver sulpahdiazine in it. Maintaining this
concentration is really important as silver when used in excessive quantities shows
toxic effects. The healing capacity of silver sulfadiazine has been subject to wide
speculation and numerous research studies. Cochrane, a non-profit organization,
does not recommend the use of silver sulfadiazine as wounds take longer to heal
when treated with medicines containing silver sulfadiazine. Despite varied market
opinions; silver sulfadiazine remains to be one of the most popular medicines for
treatment on burns as it’s is considered to be a powerful medication for burn
wounds. Additionally, silver sulfadiazine is used in majority of the hospitals in North
America as it is considered the most powerful treatment for burns. Silver
sulfadiazine has been known to cause side effects such as nausea, dizziness and
loss of appetite. Pregnant mothers and infants are recommended against the
consumption of silver sulfadiazine in order to avoid these side effects. People having
allergy to sulfa drugs are also advised not to use this medicine. These factors have
limited the use of the compound in the global market.
View Report @ http://www.transparencymarketresearch.com/silver-
sulfadiazine-market.html
Burn injuries have reached its epidemic proportions and are considered a healthcare
problem more serious than other epidemics such as polio. According to the National
Fire Protection Association (NFPA), a civilian death from fire occurs about every two
hours in the U.S., which in turn have increased the demand for the wound-care
products. Silver-containing wound dressings such as silver sulfadiazine has proved
their effectiveness and is the most widely used medicine to cure burn injuries.
Owing to this, North America has emerged as the largest consumer as well as
producer for anti-burn products. The U.S. Government grants funds for the research
and development of medicines to fight burn wounds, which has subsequently